Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. - Wikidata - awgldk - TriplyDB

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q36669223

about

Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease Autophagy: a new target for nonalcoholic fatty liver disease therapy Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients Inflammation in nonalcoholic steatohepatitis.Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle.β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice Immature myeloid cells induced by a high-fat diet contribute to liver inflammation.Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease.The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells Fat: a matter of disturbance for the immune system.Complement alternative pathway activation in human nonalcoholic steatohepatitis.What does irritable bowel syndrome share with non-alcoholic fatty liver disease?Autophagy in nonalcoholic steatohepatitis.Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang.NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.Macrophage autophagy limits acute toxic liver injury in mice through down regulation of interleukin-1β CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice Aging promotes the development of diet-induced murine steatohepatitis but not steatosis What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice: controlled by ATF3.Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease.Role of Serum Biomarkers in Early Detection of Non-Alcoholic Steatohepatitis and Fibrosis in West Virginian Children.Functions of autophagy in normal and diseased liver.Kupffer cells in non-alcoholic fatty liver disease: the emerging view.Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis Mice lacking C1q are protected from high fat diet-induced hepatic insulin resistance and impaired glucose homeostasis.Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis.c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis.CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

P2860

Q26738646-34374F2A-803F-45DA-A422-7157B835BD82 Q26751326-2596F4BF-B03C-4612-BD63-29475F5FBBBB Q26825517-C284117F-F974-4DA5-B3D4-D621A7453C52 Q27497351-118C9CC8-E9CD-4F11-8B04-95FA01C09522 Q28607750-B4AE97CC-0D52-4BF5-889A-CB87DA9D412B Q28748743-91482E61-633A-4A7F-81B2-33721A5E64E1 Q30453231-D9509DBD-5E47-4AF8-9157-FBAADEDF56E4 Q33364908-B43AA661-4B34-48EF-A652-29C11BB6178E Q33654923-5D42354C-A878-4B3F-B101-A38AA2B1D0F7 Q33781288-A3D27840-569B-4151-A25F-9C618932457C Q33805267-496077F3-0A79-4886-8F5B-7610BBD46D4D Q33864337-F1899731-766E-49B6-8DD9-98C56D05300B Q34085058-8BA27EB2-7185-4037-BF22-382E7540A8C3 Q34152594-135D8BA4-6284-44CD-B02D-8CEC7D82ED31 Q34200814-8804D783-E1C5-4B31-8A4E-4084ABF0D40E Q34317685-BFF27AAF-64A5-44BE-914E-1378327065FD Q34983471-FCEFF49B-2C5B-4E49-94CD-8A99D4C6679E Q35014344-08226A3D-7568-4EF8-8ACA-E93EA418ADEA Q35061420-6DAFC295-B22D-4682-ACD9-F91F4D159BBC Q35293633-C9992B8A-D2C6-4C2A-BBB7-ADADD1507E99 Q35607454-CF2DBB7F-A0DC-4980-ABA7-C64888141968 Q35931190-FDB8B55D-F89D-47DF-971A-F3F58F8455B2 Q36243894-D1CA30BB-4C70-46F8-A7AB-904575BC85D1 Q36405078-1DA37E0C-567D-4B22-8F8C-C1A36DCE0DB5 Q36462116-2F728DE7-ACFD-49E9-8C21-332A200411C9 Q36592306-CF46F119-7F51-4CAB-9044-5449C2ED171E Q36592331-02F25FC6-3CB7-4078-8F1E-F521CF4B8CAB Q36616784-02198673-9A9B-420E-BCFE-841B6FAD6258 Q36621495-C479D768-3CBC-4A67-969E-91909E377A16 Q36655185-4C68785E-E09B-4A8C-A14C-B2A2249257D9 Q36796803-AFBA8307-CCED-4147-A391-8CA61953B289 Q36900196-09578304-5E8B-4CA4-BCE6-4171E6BBA694 Q37107125-244C149B-410D-4F86-A534-E79647B9DEB1 Q37222183-8665542E-00F3-42EA-96A4-909FFCB52AE7 Q37291200-6F407920-48B7-4CCD-813F-50BCBE2F21FA Q37311913-02068D39-7979-44F5-8282-7F8C3CB166EE Q37362066-178F36F2-4D27-4EB6-9BD4-0931B8C52EF8 Q37376335-F72C55BF-FCEF-41B6-8EAB-63CB3D80197C Q37613264-7941380B-446C-4D34-8376-5E8B54DFE5EF Q37624585-5B9453F1-E0AA-4441-BF58-DA69B5FE4B3B

P2860

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q36669223

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

@ast

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

@en

type

label

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

@ast

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

@en

prefLabel

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

@ast

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

@en

P1433

Q36669223-95B77C7B-A81B-452C-A47A-FE3545661C2E

P1476

Q36669223-52D24BC7-FDCB-4D94-BA90-53B30A2DF6A6

P2093

Q36669223-281F7C84-4394-4CC1-A305-2F468C190961

Q36669223-5E4D1121-F6EE-48EA-BDDC-4478A4B70770

Q36669223-962A8697-5110-4923-9FAE-E2DD83706340

P2860

Q36669223-002CA617-7E0A-40A0-B7C5-9D5BEE00E34E

Q36669223-0092DDEC-2662-480C-82A3-28C739F0FCD1

Q36669223-03BD1E5D-8979-4289-AA5E-F5ED6FE1096B

Q36669223-03F2BBE1-FBDE-41E7-83AD-0486D3F15EB7

Q36669223-070638DD-6BCF-4C4C-BBC7-4AD0AF59D4D0

Q36669223-07858E08-3C6A-4C4C-8F69-16B3F049E9BE

Q36669223-0ADC9A4E-141A-44A6-94DF-79C0AF675D8B

Q36669223-0DFE1B4E-B740-4A95-B10E-0C5E5A607F40

Q36669223-0E7825E4-D435-48E1-9E5D-EE6A0ECB0670

Q36669223-0FBCD6EB-74E1-4422-96F0-D758FB9D2A39

P304

Q36669223-467E170F-21D4-42AE-821D-DA51AE5D5718

P31

Q36669223-2D2562CA-DE0C-447B-BD67-F8CA2623102E

P356

Q36669223-63E745F2-432F-4B45-89FC-FB8CF0ED4084

P407

Q36669223-40028B06-9A73-47C9-93F8-34DD5A4FED46

P433

Q36669223-E37ED9A7-55CE-4C66-9130-2E61D0EF3147

P478

Q36669223-624C8294-D6C6-4010-8291-6020A0A243A1

P577

Q36669223-C7E23691-4A28-4323-8EDD-B1D9F1168D2E

P5875

Q36669223-3809993C-2E1B-4EF1-9C9B-8924D5F9B2D3

P698

Q36669223-37A9FD27-A094-4BFA-BD8F-715B0FDF28D8

P921

Q36669223-554D1658-A49A-4803-B8D6-E5E00665EE4B

Q36669223-B5FB46C1-783D-493B-A1E8-039A6566CA54

P932

Q36669223-21F927DB-069A-4495-8967-0F8441DAF812

P356

P1433

P1476

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

@en

P2093

Jacquelyn J Maher

http://www.w3.org/2001/XMLSchema#string

James C Ryan

http://www.w3.org/2001/XMLSchema#string

Pablo Leon

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and insulin resistance

Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

Inflammation and metabolic disorders

Obesity is associated with macrophage accumulation in adipose tissue

The biology of NKT cells

Prevention of fat-induced insulin resistance by salicylate

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

P304

670-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22399

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23136651

http://www.w3.org/2001/XMLSchema#string

P698

18666225

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

3592568

http://www.w3.org/2001/XMLSchema#string